FOXO TECHNOLOGIES INC. Dividend Income Operating Paid In Cash
FOXO TECHNOLOGIES INC. (FOXO) reported Dividend Income Operating Paid In Cash of $2.47 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-06-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:DividendIncomeOperatingPaidInCash · last filed 2024-06-06
- FOXO TECHNOLOGIES INC. dividend income operating paid in cash for the quarter ending 2023-12-31 was $0.00.
- FOXO TECHNOLOGIES INC. dividend income operating paid in cash for the quarter ending 2023-09-30 was $2.46M.
- FOXO TECHNOLOGIES INC. dividend income operating paid in cash for fiscal 2023 was $2.47M.
| Period end | Dividend Income Operating Paid In Cash 3 month | Dividend Income Operating Paid In Cash 6 month | Dividend Income Operating Paid In Cash 9 month | Dividend Income Operating Paid In Cash 9 month as first filed | Dividend Income Operating Paid In Cash 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | $2.46M derived: sum of 2 quarters · filed 2024-06-06 | $2.47M 10-K · filed 2024-06-06 | ||
| 2023-09-30 | $2.46M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-06-04 | $2.47M 10-Q/A · filed 2024-06-04 | $2.47K 10-Q · filed 2024-01-19 | ||
| 2023-06-30 | $2.47K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |